Perilymphatic regulatory T cell-dendritic cell interactions represent a novel axis of immunosuppression in cancer
Cancer Cell · 2024
DOI: 10.1016/j.ccell.2024.06.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024. Verfasst von Carolina Mangana und 1 weiteren Autor:innen. Beteiligte Einrichtung: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Dendritic Cells, T-Lymphocytes, Regulatory, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Dendritic cells are critical inducers of adaptive anti-tumor immunity. However, their maturation, activation, and migration are often compromised in the tumor microenvironment. In this issue, You et al. demonstrate a novel axis of suppression of dendritic cell function mediated by interaction with regulatory T cells in perilymphatic niches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, 1090 Vienna, Austria.
- CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, 1090 Vienna, Austria. Electronic address: bmaier@cemm.oeaw.ac.at.
Zitieren
APA
Mangana, C., & Maier, B. B. (2024). Perilymphatic regulatory T cell-dendritic cell interactions represent a novel axis of immunosuppression in cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.06.016
Vancouver
Mangana C, Maier BB. Perilymphatic regulatory T cell-dendritic cell interactions represent a novel axis of immunosuppression in cancer. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.06.016
BibTeX
@article{Mangana2024,
author = {Mangana, Carolina and Maier, Barbara B},
title = {Perilymphatic regulatory T cell-dendritic cell interactions represent a novel axis of immunosuppression in cancer},
journal = {Cancer Cell},
year = {2024},
doi = {10.1016/j.ccell.2024.06.016}
}
EUVIMED